We combined data from five different databases and conducted a multicentre historical cohort study of women with breast cancer and a BRCA2 mutation, resident in North America, Europe and Australia, to identify the impact of various treatments (chemotherapy, oophorectomy, hormonal therapy, contralateral mastectomy and radiotherapy) on survival. The gene discussed is BRCA2; the disease is breast cancer.